AARTIIND505.25

Aarti Industries Ltd.

· Chemicals
₹ CrorePeersATULDEEPAKNTRTATACHEMJGCHEMCHAMBLFERTDEEPAKFERTNAVINFLUORHSCLMcap ₹18,316 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
AARTIIND
FY26
ATUL
FY26
DEEPAKNTR
FY26
TATACHEM
FY26
Peer
Median
Valuation — at last close
P/E43.71×27.49×40.88×34.18× +28%
P/B3.08×2.96×3.83×0.70×2.96× +4%
EV/EBITDA19.40×16.57×24.06×12.47×16.57× +17%
Market Cap₹18,316 Cr₹18,636 Cr₹22,503 Cr₹15,606 Cr₹18,636 Cr -2%
Growth
Revenue CAGR 3Y7.78%4.95%-0.36%-4.58%-0.36% +2261%
Revenue CAGR 5Y12.96%10.95%12.59%7.41%10.95% +18%
Net Income CAGR 3Y-8.40%10.81%-13.54%-1.36% -515%
Revenue YoY (latest Q)42.45%25.03%36.39%14.41%25.03% +70%
Net Income YoY (latest Q)257.97%91.85%207.36%-81.01%91.85% +181%
Profitability
EBITDA Margin14.09%16.43%12.43%12.38%12.43% +13%
Net Income Margin5.06%10.99%6.98%-11.76%6.98% -28%
Return on Common Equity7.04%10.77%9.38%-8.55%9.38% -25%
Return on Capital Employed8.39%10.45%10.21%1.87%10.21% -18%
Return on Assets3.15%8.73%6.34%-4.39%6.34% -50%
Credit & Quality
Total Debt/Equity0.83×0.03×0.26×0.36×0.26× +219%
Interest Coverage2.04×40.66×16.43×1.02×16.43× -88%
Scale — latest FY
Revenue / Total Income₹8,286 Cr₹6,274 Cr₹7,887 Cr₹14,584 Cr₹7,887 Cr +5%
Net Income₹419 Cr₹689 Cr₹551 Cr−₹1,715 Cr₹551 Cr -24%
Total Assets₹13,300 Cr₹7,900 Cr₹8,681 Cr₹39,031 Cr₹8,681 Cr +53%
EPS₹11.56₹230.25₹40.36₹-74.42₹40.36 -71%
Book Value per Share₹164.27₹2,138.77₹430.3₹869.61₹869.61 -81%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.